Fluoroquinolone Drug Finafloxacin 209342-40-5

 Finafloxacin CAS number is 209342-40-5, a novel fluoroquinolone drug that combines the essential features required for successful bacterial infections: for Gram-positive, Gram-negative and anaerobic pathogens Good activity. In addition, Finafloxacin has a certain effect in the treatment of Helicobacter pylori infection, eye, ear or nose infection. Microbiological evaluation in vitro and in vivo showed that Finafloxacin CAS  209342-40-5 was effective in animal infection models. Thus, the high activity of phenacetin at the site of infection is due in part to its enhanced antimicrobial activity at concentrations below neutral pH.
Studies have shown that the increased activity of phenacetin in an acidic environment is in contrast to the activity of all commercially available quinolones, which are substantially reduced in activity under these conditions. Therefore, based on all the signs associated with a low pH environment, phenacetin appears to be a good drug. The antibacterial activity profile of Finafloxacin covers most pathogens that are prevalent in urinary tract infections, intra-abdominal infections, skin infections, and other indications.
In the treatment of urinary tract infections and pyelonephritis, it has been surprisingly found that Finafloxacin completely eradicates pathogens from patients much faster than with other fluoroquinolones. The better efficacy of Finafloxacin usually shortens the treatment cycle. In particular, this shortened treatment cycle is achieved without increasing the daily dose of Finafloxacin

Thera. Category:Anti- bacterial

Cas No.:209342-40-5

Synonym: Finafloxacin;BAY35-3377,finafloxacin hydrochloride;8-cyano-1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 

Molecular Formula:C20H19FN4O4

Molecular Weight:398.3876632

Specifications:Available on request

Packing:Export worthy packing

Material Safety Data Sheet:Available on request